Mangalam Drugs re-appoints Independent Director for second term
Mangalam Drugs and Organics Limited announced that shareholders have approved the re-appointment of Shri. Praveen Saxena as an Independent Director for a second term of five consecutive years. The resolution was passed through a postal ballot process with 99.95% of the valid votes cast in favour.

*this image is generated using AI for illustrative purposes only.
Mangalam Drugs and Organics Limited has secured shareholder approval to re-appoint Shri. Praveen Saxena as an Independent Director for a second term of five consecutive years. The resolution was passed via a postal ballot conducted under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with 99.95% of valid votes cast in favour. This outcome ensures the continuity of leadership within the company's governance structure.
The postal ballot notice was sent to members on May 18, 2026, with remote e-voting facilities provided by the National Securities Depository Limited (NSDL). The voting process commenced on May 19, 2026, and concluded on June 17, 2026. Mr. Brijmohan Maheshwari, Proprietor of M/s. BMM and Associates, was appointed as the Scrutinizer to oversee the fairness and transparency of the e-voting process.
Voting Results Summary
The special resolution received overwhelming support across shareholder categories. A total of 4,500,157 votes were polled, representing 28.43% of the outstanding shares. The breakdown of the voting results is as follows:
| Category | Votes in Favor | Votes Against | % of Votes in Favor |
|---|---|---|---|
| Promoter and Promoter Group | 4,389,031 | 0 | 100.00 |
| Public - Institutional shareholders | 17,505 | 0 | 100.00 |
| Public - Non-Institution shareholders | 91,423 | 2,198 | 97.65 |
| Total | 4,497,959 | 2,198 | 99.95 |
The total number of members eligible to vote as on the record date was 25,235. While the promoter group participated actively with a 77.78% turnout of their holdings, the participation from non-institutional public shareholders was lower at 0.92%. The resolution required a special majority, which was comfortably met with the requisite approval from the members.
Procedural Compliance
The company complied with all regulatory requirements, including public advertisements in the Financial Express and Loksatta on May 19, 2026, to inform members about the ballot. The voting rights were reckoned based on the register of members as on May 15, 2026. The Scrutinizer's report confirmed that the e-voting system was blocked at the end of the voting period, and the votes were unblocked and tabulated in the presence of witnesses on June 17, 2026.
Historical Stock Returns for Mangalam Drugs & Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.30% | +0.14% | +0.71% | +22.96% | -62.85% | -79.29% |
What strategic initiatives will Shri. Praveen Saxena prioritize during his second term to drive company growth?
How will the board leverage the overwhelming shareholder support to implement new governance policies?
What impact will this leadership continuity have on investor confidence and stock performance?

































